Fintel reports that on December 11, 2024, Jefferies upgraded their outlook for ICU Medical (NasdaqGS:ICUI) from Hold to Buy.

ICU Medical, Inc. develops, manufactures, and sells innovative medical products used in infusion therapy and critical care applications. Its product portfolio includes IV smart pumps, sets ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, ...

Bridgewater Associates LP cut its position in ICU Medical, Inc. (NASDAQ:ICUI – Free Report) by 8.6% during the third quarter, ...

No-moat ICU Medical’s third-quarter results are in ... ICU will provide commercial services and promote new IV solutions products from OPF to North American customers. According to the ...

During the last three months, 4 analysts shared their evaluations of ICU Medical ICUI, revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of their recent ...